Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck KGaA
Pharma
Merck KGaA's EMD Serono inks MFN deal with Trump administration
Fertility drugmaker EMD Serono, the U.S. arm of Merck KGaA, will offer its in vitro fertilization treatments at a sharp discount on TrumpRx.
Zoey Becker
Oct 17, 2025 11:04am
Fierce Biotech
Regeneron, Sanofi receive 1- to 2-month priority review vouchers
Oct 17, 2025 8:30am
Fierce Biotech
As 2 CEOs depart, life sciences face leadership void for women
Oct 3, 2025 11:22am
Merck KGaA names new CEO amid geopolitical tensions
Sep 25, 2025 10:45am
MilliporeSigma debuts new plant as part of €440M investment
Sep 18, 2025 8:30am
Is Trump’s MFN pricing order more bark than bite?
Aug 8, 2025 9:18am
